Keryx Biopharma (KERX) Ticks Higher, Raymond James Said Positive on Auryxia Scripts
- Wall Street hits new high as post-election rally roars ahead
- Lower for longer, ECB scales back asset buys
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Oil rises above $50 despite doubts over OPEC output cut
- Pre-Open Stock Movers 12/08: (VYGR) (TLRD) (LULU) Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Keryx Biopharma (NASDAQ: KERX) Ticks Higher, Raymond James Said Positive on Auryxia Scripts
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Stifel Downgrades Timken (TKR) to Hold
- UPDATE: Stifel Downgrades CEB Inc (CEB) to Hold
- Horizon Pharma (HZNP) Stock Could Plateau Today After Drop - Mizuho
Create E-mail Alert Related CategoriesAnalyst Comments, Trader Talk
Related EntitiesRaymond James
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!